Information Provided By: 
Fly News Breaks for May 7, 2018
EW
May 7, 2018 | 08:33 EDT
After spending a day with management, Jefferies analyst Raj Denhoy raised his price target for Edwards Lifesciences to $155 from $150. The case was again made for why teens transcatheter valve growth is well supported over the short, medium and long term, Denhoy tells investors in a research note titled "Notes from the Road: The EW Story Has Legs." The TAVR market is proving bigger than forecasts and Edwards' position is secure, the analyst adds. He keeps a Buy rating on the shares.
News For EW From the Last 2 Days
There are no results for your query EW
